Fox Chase Cancer Center News

PHILADELPHIA (FEBRUARY 5, 2018) – At Fox Chase, Campbell’s research will continue to focus on the signaling that drives cancer progression, invasion, and metastasis, with the overall objective of discovering and validating new targets for drug development and finding novel biomarkers for earlier detection and therapeutic monitoring.

PHILADELPHIA (January 16, 2018) – Nurses who have graduated from a BSN program who are interested in joining the Fox Chase team are welcome, Sunday, January 28th, 2018. Nursing department leaders and staff will speak about their experiences at the hospital, and answer questions from attendees. Interested nurses will also have the chance to take a tour of the campus.

PHILADELPHIA (January 5, 2018) – The new privately funded pilot project grants were created last April as part of the Special Pledge at the annual In Vino Vita Benefit and Wine Auction, Fox Chase’s signature fundraising event.

PHILADELPHIA (January 2, 2018) – Fox Chase Cancer Center is pleased to welcome board certified radiologist Laura Levin, MD, as an assistant professor in the Department of Diagnostic Imaging.

PHILADELPHIA (December 22, 2017) – Fox Chase Cancer Center and the Lewis Katz School of Medicine are pleased to announce the winners of its American Cancer Society Institutional Research Grant (IRG) Pilot Project Competition for Junior Investigators: Sergei Grivennikov, PhD, and Elias Obeid, MD, MPH, assistant professors at Fox Chase, and Rongsheng (Ross) Wang, PhD, assistant professor at the Lewis Katz School of Medicine at Temple University.

PHILADELPHIA (December 14, 2017) – Nearly ten percent of eligible women in a recent study did not receive radiation therapy after breast conservation surgery, although it is proven to reduce the risk of recurrence. 

PHILADELPHIA (December 14, 2017) – Fox Chase Cancer Center is pleased to announce the hiring of Jason A. Incorvati, MD, who will join the Department of Hematology/Oncology as an assistant professor, and will treat patients at the new Fox Chase Cancer Center East Norriton Hospital Outpatient Center and also see breast cancer patients at the main Fox Chase campus, beginning January 1st, 2018.

PHILADELPHIA (December 10, 2017) – According to a new study, autologous hematopoietic cell transplant (HCT) administered in first remission led to longer overall survival in younger patients with mantle cell lymphoma. Researchers found that patients who received HCT once initial chemotherapy had caused remission experienced a 40 percent improvement in progression free survival and more than 20 increase in overall survival compared with eligible patients who did not receive it.